Early transition to sulfonylurea therapy in infant with DEND syndrome due to F132L ABCC8 mutation

Acta Diabetol. 2022 Sep;59(9):1251-1253. doi: 10.1007/s00592-022-01904-0. Epub 2022 Jun 1.
No abstract available

Keywords: ABCC8 gene; DEND-syndrome; Neonatal diabetes mellitus; Sulfonylurea.

MeSH terms

  • Diabetes Mellitus* / genetics
  • Humans
  • Hypoglycemic Agents
  • Infant
  • Mutation
  • Sulfonylurea Compounds* / therapeutic use
  • Sulfonylurea Receptors / genetics

Substances

  • ABCC8 protein, human
  • Hypoglycemic Agents
  • Sulfonylurea Compounds
  • Sulfonylurea Receptors